oral therapeutic vaccine V3-X
/ Immune Network
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 30, 2019
Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma
(clinicaltrials.gov)
- P1/2; N=20; Recruiting; Sponsor: Immunitor LLC; Trial completion date: Apr 2019 ➔ Apr 2020; Trial primary completion date: Feb 2019 ➔ Feb 2020
Clinical • Trial completion date • Trial primary completion date
1 to 1
Of
1
Go to page
1